Monitoring of up to 15 years effects of lipoprotein apheresis on lipids, biomarkers of inflammation, and soluble endoglin in familial hypercholesterolemia patients

BACKGROUND: Lipoprotein apheresis (LA) is considered as an add-on therapy for patients with familial hypercholesterolemia (FH). We aimed to analyze the data collected in the last 15 years from FH patients treated with LA, to elucidate the benefit of this procedure with respect to plasma lipids, biom...

Descripción completa

Detalles Bibliográficos
Autores principales: Víšek, J., Bláha, M., Bláha, V., Lášticová, M., Lánska, M., Andrýs, C., Tebbens, J. Duintjer, Igreja e Sá, Ivone Cristina, Tripská, K., Vicen, M., Najmanová, I., Nachtigal, P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7913462/
https://www.ncbi.nlm.nih.gov/pubmed/33640001
http://dx.doi.org/10.1186/s13023-021-01749-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7913462/
https://www.ncbi.nlm.nih.gov/pubmed/33640001
http://dx.doi.org/10.1186/s13023-021-01749-w

Ejemplares similares